SEC Filing Details
Document Details
Form
Filing Date
Mar 4, 2026
Document Date
Mar 4, 2026
Form Description
SCHEDULE 13D/A - Description
Filing Group
Other
Company
Akari Therapeutics
Issuer
AKARI THERAPEUTICS PLC
